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There are various mechanisms by which ectopic
mineralization can take place. Metastatic calcifica-
tion occurs when the calcium/phosphate solubility
product in extracellular fluid is exceeded, and also
when in metabolically impaired or dead tissue
mineral may be deposited as dystrophic calcifica-
tion despite normal serum levels of calcium and
phosphate.1,2 True bone formation or ectopic
ossification may be seen in some rare disorders.1
There are local factors predisposing to soft-
tissue calcification, i.e. local changes of pH, local
changes of tissue proteins with high affinity for
calcium, focal injury (infection, haematoma) and
local expression of growth factors (TGF-b). Sys-
temic factors also predispose to soft-tissue calcifi-
cation, i.e. increased calcium/phosphorus product,
the use of acetate instead of bicarbonate in dialysis
fluid, age, and associated diseases such as second-
ary hyperparathyroidism, hypoparathyroidism, ady-
namic bone disease, aluminium overload, vitamin D
intoxication and neoplasms with bone destruc-
tion.2,3
Soft-tissue calcifications, such as visceral, peri-
articular and vascular calcification, are frequently
seen in persons with advanced renal failure,
especially in those on long-term haemodialysis.2–4
We report a case of two types of ectopic calcifica-
tion in a man with end-stage renal failure.1477-6804/$ - see front matter q 2004 The Royal College of Radiolo
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A 51-year-old man with end-stage renal failure
secondary to essential hypertension, and on main-
tenance haemodialysis for the past 7 years, was
admitted for investigation of pleural effusion. He
was a non-smoker with no history of tuberculosis
contact. During the previous year he had presented
with a cough which was initially dry but became
productive with non-purulent sputum and some-
times with mild haemoptysis, associated with
dyspnoea, pleuritic chest pain and an evening low-
grade fever. He also had a painful mass in the left
hip; the pain was exacerbated by joint use. A new
mass, painless and firm, appeared 7 months later in
the left shoulder. Control of serum phosphate levels
had been difficult because of poor compliance with
calcitriol and calcium carbonate. His respiratory
symptoms persisted and he sought medical assist-
ance in October 2002, when a chest radiograph
demonstrated a large pleural effusion in the left
lung (Fig. 1a). He was immediately admitted for
investigation.
Clinical examination found a 10 cm mass over-
lying the left shoulder joint (Fig. 2a) and a 20 cm
mass in the left hip joint (Fig. 3a). The masses were
bulging and firm, without evidence of flocculation,
necrosis or ulceration. Vesicular breath sounds
were absent in the two thirds of the right
hemithorax, but systemic examination was other-
wise normal.
Results of laboratory assessments on admission
were as follows: haemoglobin 11.5 g/dl; white
blood cell count, 11.10!109/l, with 11% band;
platelets, 218!103 cells/mm3; serum creatinine,
11.1 mg/dl; serum urea, 206 mg/dl; plasma glu-
cose, 75 mg/dl; serum calcium, 8.0 mg/dl; serum
phosphate, 6.6 mg/dl; calcium/phosphate product,
52.8 mg/dl2; and serum intact parathyroidClinical Radiology Extra (2004) 59, 120–124gists. Published by Elsevier Ltd. All rights reserved.
Figure 1 (a) Plain radiography and (b) computed
tomography of the thorax reveal a large left pleural
effusion and a calcified rim of thickened pleura.
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depicted extensive periarticular soft-tissue calcifi-
cation, without evidence of bony involvement
(Figs 2b, c and 3b, c).
At diagnostic thoracentesis the white cell count
was 11.60!109/l, with 63% polymorphonuclear
cells; pH, 6.95; lactate dehydrogenase,
11.704 U/ml; and total proteins, 3.1 g/dl. Cytolo-
gical examination demonstrated haemorrhagic
smears composed predominantly of lymphocytes
and reactive mesothelial cells. Pleuroscopy and
pleural biopsy showed a non-specific inflammatory
reaction. No malignant cells or granulomas were
seen and cultures, including for acid-fast bacilli,
were negative.Figure 2 (a) Left shoulder mass. (b) Plain radiography
and (c) computed tomography of the left shoulder reveal
extensive periarticular soft-tissue calcification, without
evidence of bony involvement.Discussion
Two different mechanisms seem to be involved in
Figure 3 (a) Left hip mass. (b) Plain radiography and (c)
computed tomography of the left hip demonstrate
extensive periarticular soft-tissue calcification, without
evidence of bony involvement.
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end-stage renal failure.
Tumoral calcinosis due to long-standing hyper-
phosphataemia and persistently elevated calcium/-
phosphate product could account for the
calcification of periarticular subcutaneous tissues
around the major joints.11,12 Typically the hips and
shoulders are affected, although additional joints
such as elbows, feet, hands and wrists can become
involved.1,2,4,9,10 These soft-tissue masses of ecto-
pic calcification are usually painless, with no
apparent clinical symptoms.1–3 Because the depos-
its are extracapsular, joint mobility is not impaired
unless the tumours are particularly large.1,4,13 In a
minority of patients they can produce pain when
there is compression of adjacent neural struc-
tures.1,4
The lesions can also ulcerate the skin1,4,9 and this
complication can lead to infection, septicaemia,
anaemia, low-grade fever, regional lymphadeno-
pathy, splenomegaly and amyloidosis.1,2,12. There
are reports of tumoral calcinosis with signs of
systemic inflammation leading to fever and other
constitutional symptoms.14 These signs may mimic
infection and could therefore cause the cancella-
tion of a renal transplantation.10 The progression of
tumoral calcinosis is usually slow but variable, and
some masses can enlarge rapidly.2
The lesions of tumoral calcinosis are hard,
lobulated and firmly attached to deep fascia.1
They show a lobulated capsule with an internal
chalky and gritty deposit that is separated by
fibrous septa. Histologically the wall of the capsule
contains collagenous fibrous tissues with foreign-
body giant cells, and is lined with inflammatory
granulomatous tissue. It differs from ossification in
its lack of organization into a trabecular pattern
with a cortex and medulla.2 The fluid within the
capsule may have an appearance of milky fluid,10
and its analysis reveals high concentrations of
calcium phosphate and calcium carbonate
combinations.15
On radiographic examination, these tumours
typically appear as large aggregations of irregular,
densely calcified lobules confined to soft tissue.
Bone erosion is rare and may be the result of
repeated microtrauma to the bone which is often
caused by the large size of the masses.2 As in this
case, the joints are unaffected.1 Bone radiography
is the best method to detect and localize the
calcified masses16 and also to follow the resolution
of extraskeletal uptake.17
On the other hand, the pleural calcification is
probably dystrophic. Investigation of this patient’s
pleural effusion demonstrated an exudate with high
LDL levels and low pH, raising the suspicion of
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and culture of the pleural effusion were negative
for malignancy, tuberculosis or other infectious
organisms. Chronic local inflammatory activity was
thus probably responsible for the pleural
calcification.
In dystrophic calcification, the levels of calcium
and inorganic phosphate present in serum or
extracellular fluid are too low for spontaneous
precipitation but, once crystal nucleation has
begun, hydroxyapatite formation can follow.
Injured tissue of any kind is predisposed to
dystrophic calcification because such tissue can
release material that has nucleating properties.
One example of this phenomenon is the caseous
lesion of tuberculosis, and other diseases, such as
systemic lupus erythematosus, scleroderma and
dermatomyositis, can lead to this type of ectopic
calcification.1 Chronic inflammatory processes
involving monocyte/macrophage infiltration
further contribute directly to the calcification
process by cell–cell interaction and production of
soluble factors such as TNF-a.5 Although the levels
of calcium and phosphorus are characteristically
normal, mineral precipitation into injured tissue is
more striking and severe when the levels in
extracellular fluid of these electrolytes are
increased.1
Delay in the treatment of a parapneumonic
effusion can lead to a purulent and organized
stage. Intrapleural fibrinolytic therapy can facili-
tate thoracostomy tube drainage and prevent the
appearance of thick pleural “peel”6,7 that usually
develops after treatment of complicated parapneu-
monic effusion.6 This kind of calcification may
resolve slowly over several months6,8 but its
presence can predict failure of non-operative
treatment.7 However, the role of intrapleural
fibrinolytics and the optimal timing of surgical
intervention are unknown.7 Surgical decortication
should be reserved for selected patients with
established fibrothorax.6
Since the management of ectopic calcification is
difficult, it is better to prevent its formation, and
control of serum phosphate levels is crucial to
prevent tumoral calcinosis. Management of tumoral
calcinosis and tumour-like calcifications, particu-
larly in patients with chronic renal failure, is often
difficult and regularly unsuccessful.2,3 Usually the
treatment involves dietary phosphate restriction,
phosphate binders, intensification of dialysis treat-
ment, dialysis using a low-calcium dialysate, para-
thyroidectomy in those with high PTH levels18 and
surgical excision of the calcified masses.10 Phos-
phorus binders constitute the mainstay of serum
phosphorus level control in end-stage renal disease.Phosphorus retention is related to an imbalance
between phosphorus intake and removal by dialysis,
and is usually aggravated when vitamin D analogues
are prescribed. The amount of phosphorus removed
by standard haemodialysis is insufficient to achieve
a neutral phosphorus balance when protein intake is
O50 g/day, but additional protein restriction,
leading to decreased phosphate absorption, may
impose the risk of malnutrition. More frequent
dialysis (daily) is preferable and may achieve a
regression of the deposits.19
Good control of metabolic acidosis may also be
helpful in preventing the soft-tissue calcification.2
An alternative approach is a relatively low dialysate
calcium concentration, in an attempt to decrease
serum calcium and the calcium/phosphorus
product.
If tumoral calcinosis is associated with high
plasma PTH levels, it may reverse after surgical
correction of parathyroid overfunction.2,11,20 In
patients with aluminum intoxication, pseudotu-
moral calcifications may regress during aluminium
chelation therapy despite progression of hyperpar-
athyroidism, because aluminium may predispose to
dystrophic or metastatic calcification.21 When
calcification is associated with normal or low bone
turnover, the regression is more difficult and has
been obtained only after changing to more inten-
sive haemodialysis treatment schedules with
low-calcium dialysate10,19 or after renal transplan-
tation.22 McGregor et al. reported a case of rapid
resolution of tumoral calcinosis after successful
renal transplantation.22
Bisphosphonates, steroidal and non-steroidal
anti-inflammatory drugs have been considered for
the treatment of severe soft-tissue calcifications in
uraemic individuals, but no controlled studies are
available.2 These drugs may be beneficial by
suppressing osteoclastic activity and releasing
proinflammatory cytokines. Phanish et al. reported
a case where tumoral calcinosis in the left shoulder
caused an inflammatory reaction with excellent
response to bisphosphonates, which enabled them
to proceed with renal transplantation.8 Others
reports regarding the use of bisphosphonates in
the treatment of ectopic calcification have shown
either no therapeutic effect, inconsistent results18
or complete regression of soft-tissue calcifica-
tions.23 Radiotherapy and cortisone injections
have been helpful in reducing the tumour in some
studies.15
Surgical removal of subcutaneous calcified
masses may be helpful if they are painful, interfere
with function or are cosmetically unacceptable.1
The recurrence rate has been related to the size of
the lesion2 and it is very frequent in large masses.
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calcification: metastatic, due to hyperphosphatae-
mia and located in the hip and shoulder periarti-
cular joints, and dystrophic, due to a presumed
chronic local inflammatory response and located
within the pleura. We have not found any previous
reports of both types of calcification occurring in
the same person.References
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